ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211,787,813 | +501.8% | 430,787 | +377.0% | 0.06% | +533.3% |
| Q2 2023 | $35,194,568 | +64.9% | 90,305 | +57.7% | 0.01% | +50.0% |
| Q1 2023 | $21,337,284 | -22.7% | 57,269 | -21.4% | 0.01% | -25.0% |
| Q4 2022 | $27,589,052 | +62.9% | 72,827 | +51.8% | 0.01% | +60.0% |
| Q3 2022 | $16,939,000 | +32.0% | 47,980 | +41.6% | 0.01% | +25.0% |
| Q2 2022 | $12,835,000 | +20.8% | 33,874 | +0.5% | 0.00% | +33.3% |
| Q1 2022 | $10,628,000 | -39.4% | 33,706 | -32.7% | 0.00% | -25.0% |
| Q4 2021 | $17,534,000 | +19.6% | 50,070 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $14,658,000 | +1.7% | 48,535 | +1.4% | 0.00% | 0.0% |
| Q2 2021 | $14,408,000 | -81.1% | 47,856 | -82.7% | 0.00% | -80.0% |
| Q1 2021 | $76,061,000 | +5.8% | 276,195 | +13.0% | 0.02% | -4.8% |
| Q4 2020 | $71,858,000 | -10.0% | 244,341 | -19.7% | 0.02% | -22.2% |
| Q3 2020 | $79,832,000 | -2.7% | 304,097 | -16.5% | 0.03% | -6.9% |
| Q2 2020 | $82,043,000 | +22255.0% | 364,262 | +11209.0% | 0.03% | – |
| Q3 2019 | $367,000 | -80.7% | 3,221 | -76.0% | 0.00% | – |
| Q2 2019 | $1,903,000 | -56.9% | 13,441 | -62.0% | 0.00% | -100.0% |
| Q1 2019 | $4,420,000 | -8.8% | 35,401 | -29.9% | 0.00% | -50.0% |
| Q4 2018 | $4,849,000 | -51.8% | 50,471 | -61.9% | 0.00% | -33.3% |
| Q3 2018 | $10,059,000 | – | 132,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |